Evidence map›Paper›PMID 39799278›Full record

ArticleJournal of human hypertension2025

Red cell distribution width as a cardiovascular risk predictor in adults with hypertension in sub-Saharan Africa.

Olayinka Rasheed Ibrahim, Kojo Awotwi Hutton-Mensah, Funmi Temidayo Adeniyi, George Bediako Nketiah, Adaku M Nwankwo, Abukari Yakubu Natogmah, James Ayodele Ogunmodede, Dike Ojji, Adesola Olumide, Biodun Sulyman Alabi and 2 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of human hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Olayinka Rasheed IbrahimDepartment of Pediatrics, Division of Clinical Medicine, University of Global Health Equity, Kigali, Rwanda. ibroplus@gmail.com.ORCID http://orcid.org/0000-0002-2621-6593
Kojo Awotwi Hutton-MensahDirectorate of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Funmi Temidayo AdeniyiDepartment of Pediatrics, University College Hospital, Ibadan, Nigeria.
George Bediako NketiahDepartment of Family Medicine/Polyclinic, Korle Bu Teaching Hospital, Accra, Ghana.
Adaku M NwankwoDepartment of Internal Medicine, Gwarimpa General Hospital, Abuja, Nigeria.
Abukari Yakubu NatogmahSt Anthony Ann Hospital, Donyina, Ghana.
James Ayodele OgunmodedeDepartment of Medicine, University of Ilorin, Ilorin, Nigeria.
Dike OjjiDepartment of Internal Medicine, University of Abuja Teaching Hospital, FCT, Abuja, Nigeria.
Adesola OlumideInstitute of Child Health, University of Ibadan, Ibadan, Nigeria.
Biodun Sulyman AlabiDepartment of ENT, University of Ilorin, Ilorin, Nigeria.
Daniel F SarpongOffice of Health Equity Research, Yale School of Medicine, New Haven, CT 06510, USA.
Olugbenga Ayodeji MokuoluDepartment of Pediatrics and Child Health, University of Ilorin, Ilorin, Nigeria.ORCID http://orcid.org/0000-0001-8273-5876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Red cell distribution width (RDW) quantifies the degree of variation in erythrocyte size, is identified as a potential marker of adverse cardiovascular events, and may be a surrogate marker for assessing cardiovascular disease (CVD) risk in low-resource settings. We evaluated RDW as a predictor of CVD risk compared to the World Health Organization (WHO) CVD risk score among adults with hypertension attending primary healthcare centers (PHCs) in Ghana and Nigeria. Adults with hypertension attending selected PHCs in Ghana and Nigeria participated in a cross-sectional study. Each participant underwent blood pressure (BP) measurement and laboratory evaluation (RDW, total cholesterol, and fasting blood sugar) following standard methods. We recruited 319 adults aged 40-74 years from the study sites. The mean (standard deviation) RDW was 13.96 (1.1%). The median CVD risk score was 8.11% [interquartile range (IQR) 4.00 to 11.00]. For participants with hemoglobin (Hb) levels ≥ 12 g/dL, RDW showed positive correlations with age (r = 0.136; p = 0.042); systolic BP (r = 0.183; p = 0.006), diastolic BP (r = 0.206, p = 0.002) and WHO CVD risk scores (r = 0.166, p = 0.013). Multiple linear regression showed an independent association between RDW and WHO CVD risk scores with an upward gradient, and was most significant at 3rd quartiles. Using receiver operating characteristic curve, the C-statistic was 0.673 (95% confidence interval: 0.618 to 0.724), p = 0.031. With a cut-off of >14, the RDW demonstrated a sensitivity of 81.82% and specificity of 55.84%. This study shows that at Hb levels ≥ 12 g/dL, RDW modestly predicted CVD risk in adults with hypertension in sub-Saharan Africa.

Indexed as

Cardiovascular DiseasesErythrocyte IndicesErythrocytesHypertensionAdultAgedBiomarkersBlood PressureCross-Sectional StudiesFemaleGhanaHeart Disease Risk FactorsHumansMaleMiddle AgedNigeriaBiomarkers

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.